MediPharm Labs Corp. (TSE:LABS – Get Free Report) shares traded down 11.1% during trading on Friday . The company traded as low as C$0.08 and last traded at C$0.08. 471,385 shares changed hands during trading, an increase of 108% from the average daily volume of 226,884 shares. The stock had previously closed at C$0.09.
MediPharm Labs Stock Down 13.9%
The company has a debt-to-equity ratio of 0.05, a current ratio of 3.02 and a quick ratio of 3.10. The company has a market cap of C$32.93 million, a P/E ratio of -3.88 and a beta of -0.53. The company has a 50 day moving average of C$0.08 and a 200-day moving average of C$0.07.
MediPharm Labs Company Profile
Founded in 2015, MediPharm Labs specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API), and advanced derivative products produced in a GMP-certified facility with ISO-standard clean rooms. MediPharm has invested in an expert research-driven team, state-of-the-art technology, advanced purification methodologies, and purpose-built facilities to deliver pure, trusted, precision-dosed cannabinoid products for domestic and international markets.
Further Reading
- Five stocks we like better than MediPharm Labs
- Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop
- Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs?
- The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story
- Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
